Loading
Life sciences · Journal article
Sarps Journal of Advanced Research in Plant Science · September 4, 2026
A consensus or society position rather than new primary data.
This is a narrative review of bioactive plant compounds (allicin, curcumin, flavonoids, resveratrol) examined in randomized controlled trials for cardiovascular benefits, with discussion of mechanisms, dosing, and safety. The source summarizes promising findings on blood pressure, cholesterol, endothelial function, and exercise tolerance, but explicitly states that evidence is not a substitute for conventional care and acknowledges gaps in clinical translation.
Narrative review. Intervention: Bioactive molecules from medicinal and aromatic plants (allicin from garlic, curcumin from turmeric, flavonoids from hawthorn, resveratrol from grapes).
Garlic extract has shown measurable reductions in systolic blood pressure among hypertensive patients Hawthorn extract has supported better exercise endurance in people with chronic heart failure Curcumin appears to improve endothelial function via flow-mediated dilation
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
A narrative review summarizing bioactive plant compounds and their cardiovascular effects from clinical trials, offering practical information on dosage and safety but without new primary data or a systematic synthesis.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Heart disease keeps a grip on things, like the worlds biggest killer, and that grim reality has sort of pushed scientists and regular people back toward something old school: plants. This article kinda looks at how bioactive molecules in medicinal and aromatic plants might support cardiovascular health, drawing from peer-reviewed clinical trials and also broader global health data. Cardiovascular diseases caused an estimated 19.8 million deaths worldwide in 2022, according to the World Health Organization, and that makes prevention feel more urgent than ever. Compounds like allicin from garlic, curcumin from turmeric, flavonoids from hawthorn, and resveratrol from grapes have each been examined in randomized controlled trials for possible effects on blood pressure, cholesterol, and the performance of blood vessels. Garlic extract for instance has shown measurable reductions in systolic blood pressure among hypertensive patients, while hawthorn extract has supported better exercise endurance in people living with chronic heart failure. Curcumin seems to help the inner lining of blood vessels, improving what researchers call flow mediated dilation. The article also moves through the biological mechanisms behind these effects, including antioxidant activity, anti-inflammatory signaling, and lipid regulation, and it provides a comparative table that summarizes clinical findings for the main compounds discussed. It even gets into the practical details: dosage ranges used in trials, safety concerns, drug interactions, and the gap between promising lab results and real-world clinical guidance. While the evidence is encouraging, it is not a substitute for conventional cardiology care, and the piece is honest about where the research still comes up short.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.